BLISS GVS PHARMA
|
The Current P/S Ratio of BLISS GVS PHARMA is 2.79.
| Share Price | ₹229.2 | Apr 01,2026 |
| Market Cap | ₹2,424.9 Cr | |
| Sales-TTM | ₹868.1 Cr | TTM-Consolidated Results |
| Price/Sales | 2.79x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BLISS GVS PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹2,424.9 Cr] as on Apr 01,2026
(/) Sales [ ₹868.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.79x ]
Thus, for BLISS GVS PHARMA , the investors are currently willing to pay '2.79 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BLISS GVS PHARMA !
The chart below summarizes the trend in P/S Ratio of BLISS GVS PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BLISS GVS PHARMA
PS Ratio Performance Analysis for BLISS GVS PHARMA
- BLISS GVS PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.38x.
- BLISS GVS PHARMA 's operated at median p/e ratio of 1.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BLISS GVS PHARMA 's p/e ratio peaked in Mar2021 at 1.76x.
- BLISS GVS PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0.99x.
How does BLISS GVS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BLISS GVS PHARMA | 868.1 | 2.79 | 2,424.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.30 | 414,713.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.20 | 156,811.0 |
| CIPLA LTD | 28,351.1 | 3.41 | 96,602.7 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 10.91 | 139,052.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.91 | 100,927.0 |
| MANKIND PHARMA LTD | 13,914.1 | 5.94 | 82,613.1 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.33 | 86,883.3 |
| LUPIN LTD | 26,150.5 | 3.97 | 103,944.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.35 | 77,949.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.25 | 56,293.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BLISS GVS PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.35x |
| Max industry PS | 15.20x |
| Median industry PS | 3.97x |
| Average industry PS | 6.03x |
You may also like the below Video Courses